Nusano ads

In a new column, Nusano CEO Chris Lowe highlights the urgent need for new solutions in critical minerals development and calls on government, industry and communities to come together for a "Declaration of Critical Minerals Independence."

Radiopharma trials can’t afford slow timelines. Dr. Luke Nordquist, Founder of XCancer, joins Talk Radioisotopes to discuss how his team is reimagining trial access across the U.S.—from community clinics to major cancer centers. In this episode: - Why speed is everything in clinical research - How XCancer bridges industry and patient needs - What’s next for decentralized oncology ▶️ Catch the full episode now. #Radiopharmaceuticals #DecentralizedTrials #NuclearMedicine #TalkRadioisotopes

How do you get promising radiopharmaceuticals to patients - faster? In this episode of Talk Radioisotopes, Dr. Luke Nordquist, Founder & CEO of XCancer, shares how his national trial network is streamlining oncology research and unlocking new treatment options. Hear about: - The need for decentralized clinical trial models - XCancer’s rapid start-up approach - The biggest bottlenecks in radiopharma access ▶️ Listen to the full conversation with Nusano’s Arjun Murthy. #Radiopharma #ClinicalTrials #OncologyResearch #TalkRadioisotopes

How do we accelerate the science behind theranostics? In this episode of Talk Radioisotopes, Prof. Suzanne Lapi - Director of the UAB Cyclotron Facility - dives into the future of novel isotopes and how academia is driving translational research in nuclear medicine. Highlights include: - Advancements in isotope production - Academic-industry collaboration in theranostics - Challenges in scaling next-gen radiopharmaceuticals ▶️ Hear the full conversation with Nusano’s Arjun Murthy. #Theranostics #NuclearMedicine #IsotopeProduction #TalkRadioisotopes

From lab bench to bedside - what does it take to bring new isotopes into clinical use? Prof. Suzanne Lapi joins Talk Radioisotopes to discuss her work at UAB, how isotope production is evolving, and why cross-sector collaboration is key to advancing cancer care. Tune in to learn: - What’s driving demand for novel theranostic isotopes - How universities are bridging research and application - The critical role of radiochemistry in oncology’s future ▶️ Listen to the full episode now. #Radiopharma #Isotopes #CancerResearch #TalkRadioisotopes

What does it take to bring a radiopharma brand to life - from scratch? Paul Schrimpf, Proprietor at Cyrall and former marketing lead at Curium, shares what works (and what doesn’t) when it comes to launching, positioning, and building trust in the nuclear medicine space. 🎧 Tune in to hear: - Go-to-market lessons - Brand-building in science - The power of clarity in messaging #Radiopharma #HealthTechMarketing #NuclearMedicine #TalkRadioisotopes